Month: June 2016

THURSDAY, June 30, 2016 (HealthDay News) — Many people think electronic cigarettes are a safer alternative to tobacco cigarettes, but a new study suggests that’s not the case. In laboratory experiments on cultured cells, researchers from the University of California, Los Angeles, found that toxic substances and nanoparticles in e-cigarette vapors caused 85 percent of
0 Comments
June 30, 2016, by Douglas R. Lowy, M.D. Vice President Joe Biden addresses attendees of the Cancer Moonshot Summit held at Howard University. Credit: White House Yesterday, I attended the Cancer Moonshot Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, held at Howard University in Washington, DC. In addition to this Summit,
0 Comments
June 27, 2016, by NCI Staff Three cancer patients and their doctor, Anthony L. Back, M.D. — an oncologist who is also a national expert in doctor-patient communication share their perspectives on their cancer prognoses. Learn key points about prognosis and how to talk about it, and gain valuable insight from the personal ways each
0 Comments
June 23, 2016, by Douglas R. Lowy, M.D. Vice President Joe Biden speaks to the National Cancer Moonshot Initiative’s Blue Ribbon Panel during its June 13, 2016, meeting. Credit: The White House / David Lienemann I hope that, by now, most in the cancer community have seen Vice President Biden’s address at the 2016 annual meeting
0 Comments
June 22, 2016, by NCI Staff Credit: National Cancer Institute Results from a recent clinical trial showed that extending adjuvant therapy with an aromatase inhibitor to 10 years after initial treatment can have important benefits for postmenopausal women with early-stage hormone receptor (HR)–positive breast cancer. The longer treatment improved 5-year disease-free survival and decreased the women’s
0 Comments
June 17, 2016, by NCI Staff Attendees flock to a poster session at the 2016 American Society of Clinical Oncology annual meeting. Credit: ASCO/Zach Boyden-Holmes 2016 Findings from several early-stage clinical trials featured at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago last week reflect the dominant trends in cancer treatment: targeted
0 Comments
June 16, 2016, by NCI Staff NCI constantly publishes new information on its websites, so periodically we provide updates on new content of interest to the cancer community. Genomic Data Commons Launched On June 6, Vice President Joe Biden announced the launch of the Genomic Data Commons (GDC), an NCI-supported open-access database for sharing genomic
0 Comments
Spring is the perfect time to take your fitness outdoors. Not only is it a great opportunity to get your fresh-air fix and boost your vitamin D levels – it’s not called the sunshine vitamin for nothing, you know! It’s also the PERFECT excuse to get some new kicks! Whatever type of running you prefer,
0 Comments
June 14, 2016, by NCI Staff So-called liquid biopsies assess mutations and other changes in DNA shed from tumors into the blood. Credit: Jonathan Bailey / NHGRI In the largest study of its kind to date, a test that assesses DNA mutations and other changes in genetic material shed from tumors into the blood—a so-called
0 Comments
June 9, 2016, by NCI Staff Credit: National Cancer Institute The standard treatment that some patients with brain cancer receive is likely to change, based on findings from two large clinical trials presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago this week. Both trials showed that administering the chemotherapy drug
0 Comments
This learning portfolio builds skills to drive change that results in better care, healthier children and smarter spending. Learn from industry experts why population health matters and from your professional peers at children’s hospitals on how it works. View Essentials in Population Health Webinar Series.  Past webinars Member Highlight Webinar: Launching a Clinically Integrated Network to Meaningfully
0 Comments
June 6, 2016, by NCI Staff Researchers have developed an antibody derived from patients with early-stage lung cancer that enlists the immune system to destroy cancer cells. The antibody killed tumor cells in cell lines of several different cancer types and slowed tumor growth in mouse models of brain and lung cancer without obvious evidence
0 Comments
June 3, 2016, by NCI Staff Pathology slide of a kidney tumor Credit: Wikimedia The Food and Drug Administration (FDA) recently approved two drugs for the treatment of patients with advanced kidney cancer. Both approvals are for patients whose cancers have progressed after receiving prior treatment with drugs that block tumor blood vessel growth, known
0 Comments
June 2, 2016, by NCI Staff NCI researchers have developed a risk model-based approach for selecting smokers and former smokers who may be candidates for lung cancer screening with low-dose computed tomography (CT). Using data from two lung cancer screening studies and a U.S. health survey, the researchers estimated that the new approach might prevent
0 Comments